tiprankstipranks
AbbVie: Shift in Humira sales volume to biosimilar ‘playing out as anticipated’
The Fly

AbbVie: Shift in Humira sales volume to biosimilar ‘playing out as anticipated’

Sees FY24 U.S Humira sales $7.4B, down $400M from prior view.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App